INVITROCUE (HONG KONG) LIMITED

Services :
Using advanced organoid technology, Invitrocue has developed a personalised test, Onco-PDO (Patient-Derived-Organoids), that allows physicians to more effectively personalise cancer treatment for their patients. The Onco-PDO test is a chemosensitivity and chemoresistance test that offers a more targeted and personalised approach to cancer treatment by creating a clinically-relevant predictive in vitro model that quantifies tumour response to stand-of-care chemotherapeutics. The information provided by this test assists physician in developing a more informed and individually tailored treatment for cancer patient.

Invitrocue’s Laboratory Facilities established in Europe and Asia, are an important milestone in the international expansion of Invitrocue’s capability to help caner patients receive the “Right Drug at the Right Time”.

Products :
Proprietary HiMice (Humanised Mice) are a humanised mouse model with a stably reconstituted human immune system. Our animal models have enabled research in areas such as oncology, liver disease, auto-immune and infectious diseases.